Zheng Z - Search Results

1

Zheng Z, Wang L, Cheng S, Wang Y, Zhao W. Zheng Z, et al. Adv Exp Med Biol. 2020;1207:625-631. doi: 10.1007/978-981-15-4272-5_45. Adv Exp Med Biol. 2020. PMID: 32671780 Review.

2

Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma.

Dong LH, Cheng S, Zheng Z, Wang L, Shen Y, Shen ZX, Chen SJ, Zhao WL. Dong LH, et al. Among authors: zheng z. J Hematol Oncol. 2013 Jul 18;6:53. doi: 10.1186/1756-8722-6-53. J Hematol Oncol. 2013. PMID: 23866964 Free PMC article.

3

[Mechanism of inhibiting the cell growth in diffuse large B-cell lymphoma by valproic acid combined with temsirolimus].

Zheng Z, Zhao Y, Dong LH, Wang L, Cheng S, Zhao WL. Zheng Z, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1441-7. doi: 10.7534/j.issn.1009-2137.2013.06.014. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370026 Chinese.

4

c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors.

Zheng Z, Cheng S, Wu W, Wang L, Zhao Y, Shen Y, Janin A, Zhao WL. Zheng Z, et al. J Hematol Oncol. 2014 Dec 5;7:88. doi: 10.1186/s13045-014-0088-y. J Hematol Oncol. 2014. PMID: 25477070 Free PMC article.

5

Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.

Jiang L, Gu ZH, Yan ZX, Zhao X, Xie YY, Zhang ZG, Pan CM, Hu Y, Cai CP, Dong Y, Huang JY, Wang L, Shen Y, Meng G, Zhou JF, Hu JD, Wang JF, Liu YH, Yang LH, Zhang F, Wang JM, Wang Z, Peng ZG, Chen FY, Sun ZM, Ding H, Shi JM, Hou J, Yan JS, Shi JY, Xu L, Li Y, Lu J, Zheng Z, Xue W, Zhao WL, Chen Z, Chen SJ. Jiang L, et al. Among authors: zheng z. Nat Genet. 2015 Sep;47(9):1061-6. doi: 10.1038/ng.3358. Epub 2015 Jul 20. Nat Genet. 2015. PMID: 26192917

6

MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.

Yan ZX, Zheng Z, Xue W, Zhao MZ, Fei XC, Wu LL, Huang LM, Leboeuf C, Janin A, Wang L, Zhao WL. Yan ZX, et al. Among authors: zheng z. Biomed Res Int. 2015;2015:197241. doi: 10.1155/2015/197241. Epub 2015 Sep 7. Biomed Res Int. 2015. PMID: 26436088 Free PMC article.

7

MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells.

Zheng Z, Xu PP, Wang L, Zhao HJ, Weng XQ, Zhong HJ, Qu B, Xiong J, Zhao Y, Wang XF, Janin A, Zhao WL. Zheng Z, et al. J Exp Clin Cancer Res. 2017 Jun 21;36(1):82. doi: 10.1186/s13046-017-0551-z. J Exp Clin Cancer Res. 2017. PMID: 28637496 Free PMC article.

8

MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.

Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, Qu B, Zhao Y, Wang L, Zhao WL. Zheng Z, et al. Mol Cancer. 2019 Mar 30;18(1):54. doi: 10.1186/s12943-019-0977-3. Mol Cancer. 2019. PMID: 30925928 Free PMC article.

9

Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma.

Yan ZX, Li L, Wang W, OuYang BS, Cheng S, Wang L, Wu W, Xu PP, Muftuoglu M, Hao M, Yang S, Zhang MC, Zheng Z, Li J, Zhao WL. Yan ZX, et al. Among authors: zheng z. Clin Cancer Res. 2019 Dec 1;25(23):6995-7003. doi: 10.1158/1078-0432.CCR-19-0101. Epub 2019 Aug 23. Clin Cancer Res. 2019. PMID: 31444250 Clinical Trial.

10

Autophagy and Leukemia.

Zheng Z, Wang L, Cheng S, Wang Y, Zhao W. Zheng Z, et al. Adv Exp Med Biol. 2020;1207:601-613. doi: 10.1007/978-981-15-4272-5_43. Adv Exp Med Biol. 2020. PMID: 32671778 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,557 results

Search Page